M1-20
M1-20 is a CDK1 inhibitor. M1-20 promotes CDK1 ubiquitination by CUL4-DDB1-DCAF1 complexes and degradation through the proteasome pathway. M1-20 abolishes the formation of CDK1/CCNB1 complexes. M1-20 has significant anticancer activity of spontaneous breast cancer in FVB/N MMTV-PyVT mice model[1].
Product Specifications
UNSPSC
12352209
Target
CDK
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
O=C(N[C@H](CCCNC(N)=N)C(N[C@H](CCCNC(N)=N)C(N[C@H](CCCNC(N)=N)C(N[C@H](CCC(N)=O)C(N[C@H](CCCNC(N)=N)C(N[C@H](CCCNC(N)=N)C(N[C@H](CCCCN)C(N[C@H](CCCCN)C(N[C@H](CCCNC(N)=N)C(N[C@H](CC(C)C)C(NCC(N1[C@H](CCC1)C(N[C@H](CC2=CC=CC=C2)C(N[C@H](CO)C(N[C@H]([C@H](C)CC)C(N[C@H](CC(O)=O)C(N[C@H](CC(C)C)C(N[C@H](CC(C)C)C(N[C@H]([C@H](C)CC)C(N[C@H](CCCCN)C(N[C@H](CO)C(N[C@H](CC(C)C)C(N[C@H](CO)C(N[C@H](CC(O)=O)C(N[C@H](CC(N)=O)C(N[C@H](CCSC)C(N[C@H]([C@@H](O)C)C(N[C@H](CC(O)=O)C(N[C@H](CC(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CN
Molecular Formula
C153H269N53O43S
Molecular Weight
3571.17
References & Citations
[1]Bu H, et al. The antitumor peptide M1-20 induced the degradation of CDK1 through CUL4-DDB1-DCAF1-involved ubiquitination. Cancer Gene Ther. 2025 Jan;32 (1) :61-70.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
CDK1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
IRTAMSCD90230H12CBL25UG 25 µg
Anti Mouse CD90.2 Flow Cytometry Monoclonal Clone 30H12 Biotin 25ug
Sign In for Pricing
View Details 
MBS6465051-01 0.1 mL
BCAS3, CT (Breast Carcinoma-amplified Sequence 3, GAOB1, Maab1 Protein, BCAS3) (MaxLight 750)
Sign In for Pricing
View Details MBS6465051-02 5x 0.1 mL
BCAS3, CT (Breast Carcinoma-amplified Sequence 3, GAOB1, Maab1 Protein, BCAS3) (MaxLight 750)
Sign In for Pricing
View Details 
LS200810-100ug 100 µg
ALG1L (NM_001015050) Human Over-expression Lysate
Sign In for Pricing
View Details